GMP

Results: 1048



#Item
861Technology assessment / Risk management / Evaluation / Reliability engineering / Risk assessment / Risk / Probability / Impact assessment

Dear Sir/Madam, Please find below the feedback from Sandoz on guidelines on the formalised RA for ascertaining the appropriate GMP for excipients of medicinal products for human use Best regards, Marc Leeflang

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-11-07 08:57:36
862Validation / Validity / Pharmaceutical industry / Clinical research / Quality

Comments from the European Industrial Pharmacists Group on the Revised GMP Guidelines Chapters 3 and 5

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-11-07 09:04:05
863European Free Trade Association / Parallel import / Traceability / International relations / Technology / Business / EFTA Court / Clinical research / Qualified Person

EAEPC contribution to the public consultation on the revision of EU GMP Annex 16: ‘Certification by a Qualified Person and Batch Release’   Brussels, 14th January 2014 General Comments

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2014-01-31 06:07:24
864Qualified Person / Computing / QP / Software / Pharmaceuticals policy / Clinical research

BPIs Comments on GMP Draft Annex 16

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-11-28 04:09:47
865Ethics / Actuarial science / Project management / Security / Risk assessment / Comment / Systems engineering process / Management / Risk / Risk management

30 April 2013 Submission of comments on Risk Assessment for GMP for Excipients Comments from: Name of organisation or individual

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-11-07 08:57:31
866Pharmacology / Food safety / Good manufacturing practice / CEFIC / Excipient / Research / Health / Business / International Pharmaceutical Excipients Council / Pharmaceutical industry / Pharmaceuticals policy / Clinical research

Brussels, 29th April, 2013 Subject : Public consultation on the Draft Guidelines on the formalised risk assessment for ascertaining the appropriate GMP for excipients of medicinal products for human use Dear Sir/Madam, E

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-11-07 08:59:21
867Technology / Energy development / Sustainable building / Bulgarian Energy Holding / Energy conservation / Energy audit / Sustainable energy / Maritsa Iztok Complex / NEK EAD / Energy / Energy economics / Energy policy

Report on Analysis of Results SEE-GREEN Grundtvig[removed]LLP[removed]IT-GRUNDTVIG-GMP

Add to Reading List

Source URL: www.see-green.eu

Language: English - Date: 2014-02-20 09:14:56
868Energy conservation / Sustainable building / Environment / Environmental issues with energy / Sustainable energy / Energy service company / Energy / Energy economics / Energy policy

SEE-GREEN Grundtvig[removed]LLP[removed]IT-GRUNDTVIG-GMP SEE-GREEN: Report of Analysis

Add to Reading List

Source URL: www.see-green.eu

Language: English - Date: 2014-02-18 17:26:26
869

第三篇 科技活動與成就-應用研究與技術發展 業及追蹤管理,並策劃使 GMP 認證商品優

Add to Reading List

Source URL: 59.56.176.111

Language: Korean - Date: 2011-01-11 23:24:57
    870Qualified Person / EudraLex / Directive / Health / Science / Pharmaceuticals policy / Clinical research / Medicinal product

    DELEGATED ACT ON THE PRINCIPLES AND GUIDELINES OF GMP FOR ACTIVE SUBSTANCES IN MEDICINAL PRODUCTS FOR HUMAN USE Response of the Czech Republic to the Concept Paper submitted for public consultation 1. Extension of the Di

    Add to Reading List

    Source URL: ec.europa.eu

    Language: English - Date: 2013-10-09 09:41:53
    UPDATE